[HTML][HTML] The pattern of time to onset and resolution of immune-related adverse events caused by immune checkpoint inhibitors in cancer: a pooled analysis of 23 …
SQ Tang, LL Tang, YP Mao, WF Li, L Chen… - Cancer Research and …, 2021 - ncbi.nlm.nih.gov
Purpose The occurrence pattern of immune-related adverse events (irAEs) induced by
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials and …
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials and …
The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical …
SQ Tang, LL Tang, YP Mao, WF Li, L Chen… - Cancer Research and …, 2021 - kiss.kstudy.com
Purpose The occurrence pattern of immune-related adverse events (irAEs) induced by
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials and …
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials and …
[PDF][PDF] The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 …
SQ Tang, LL Tang, YP Mao, WF Li, L Chen, Y Zhang… - 2021 - e-sciencecentral.org
Purpose The occurrence pattern of immune-related adverse events (irAEs) induced by
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials and …
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials and …
[HTML][HTML] The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 …
SQ Tang, LL Tang, YP Mao, WF Li, L Chen… - Cancer Research and …, 2020 - e-crt.org
Purpose The occurrence pattern of immune-related adverse events (irAEs) induced by
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials and …
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials and …
The pattern of time to onset and resolution of immune-related adverse events caused by immune checkpoint inhibitors in cancer: A pooled analysis of 23 clinical trials …
SQ Tang, C Xu, LL Tang, YP Mao, WF Li, L Chen… - 2020 - ascopubs.org
e15110 Background: Immune checkpoint inhibitors (ICIs) yield remarkable clinical efficacy in
the treatment of cancer. With the increasing use of ICI therapies, the dissemination of …
the treatment of cancer. With the increasing use of ICI therapies, the dissemination of …
The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical …
SQ Tang, LL Tang, YP Mao, WF Li… - Cancer research …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose The occurrence pattern of immune-related adverse events (irAEs) induced by
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials and …
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials and …
The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical …
SQ Tang, LL Tang, YP Mao, WF Li, L Chen… - Cancer Research and …, 2021 - dbpia.co.kr
Purpose The occurrence pattern of immune-related adverse events (irAEs) induced by
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials and …
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials and …
The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical …
SQ TANG, LL TANG, YP MAO, WF LI… - Cancer Research …, 2021 - pesquisa.bvsalud.org
Purpose@# The occurrence pattern of immune-related adverse events (irAEs) induced by
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear.@* Materials and …
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear.@* Materials and …
The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical …
SQ Tang, LL Tang, YP Mao, WF Li, L Chen… - Cancer Research and …, 2021 - cir.nii.ac.jp
抄録< jats: p> Purpose The occurrence pattern of immune-related adverse events (irAEs)
induced by immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials …
induced by immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials …
The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical …
SQ Tang, LL Tang, YP Mao, WF Li, L Chen… - Cancer Research and …, 2020 - europepmc.org
Purpose The occurrence pattern of immune-related adverse events (irAEs) induced by
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials and …
immune checkpoint inhibitor (ICI) in cancer treatment remains unclear. Materials and …